Name | Bivatuzumab |
---|
Description | Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells[1]. |
---|---|
Related Catalog | |
In Vitro | Bivatuzumab (10 μg/mL) 能够标记 STS 细胞中的 CD44v6 [1]。 |
References |
No Any Chemical & Physical Properties |